Host: |
Goat |
Applications: |
Pep-ELISA/WB/IHC |
Reactivity: |
Human/Mouse/Rat/Pig/Cow |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Goat polyclonal antibody anti-MRG15/MORF4L1 (N-Term) is suitable for use in ELISA, Western Blot and Immunohistochemistry research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. NA |
Purification: |
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. |
Concentration: |
0.5 mg/mL |
Dilution Range: |
Peptide ELISA: antibody detection limit dilution 1:128000.WB: Approx 37kDa band observed in nuclear lysates of cell lines HepG2 and NIH3T3 and approx 40kDa band observed in Mouse, Rat and Pig Liver lysates (calculated MW of 37.2kDa according to |
Storage Instruction: |
Store at-20°C on receipt and minimise freeze-thaw cycles. |
Gene Symbol: |
MORF4L1 |
Gene ID: |
10933 |
Uniprot ID: |
MO4L1_HUMAN |
Immunogen Region: |
N-Term |
Accession Number: |
NP_006782.1; NP_996670.1 |
Specificity: |
This antibody is expected to recognise isoform 1 (NP_006782.1) and isoform 2 (NP_996670.1). |
Immunogen Sequence: |
APKQDPKPKFQEG |
Protein Name | Mortality Factor 4-Like Protein 1Morf-Related Gene 15 ProteinMrg15Protein Msl3-1Transcription Factor-Like Protein Mrg15 |
Database Links | Reactome: R-HSA-3214847 |
Cellular Localisation | Nucleus |
Alternative Antibody Names | Anti-Mortality Factor 4-Like Protein 1 antibodyAnti-Morf-Related Gene 15 Protein antibodyAnti-Mrg15 antibodyAnti-Protein Msl3-1 antibodyAnti-Transcription Factor-Like Protein Mrg15 antibodyAnti-MORF4L1 antibodyAnti-MRG15 antibodyAnti-FWP006 antibodyAnti-HSPC008 antibodyAnti-HSPC061 antibodyAnti-PP368 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance